H.S. Pharma Private Limited - Company Profile

It is a pharma private limited company based in Kaithal, Haryana, India, established in 2013.
2013 Kaithal, Haryana, India Active
Last Updated:
Access Report
About H.S. Pharma Private Limited

H.S. Pharma Private Limited, a active private limited company, was established on 29 May 2013 in Kaithal, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233HR2013PTC049371. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Dilbag Singh (Director), Ram Paul (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 189 A/16, Nehru Garden Near Jat School, Kaithal, Haryana, 136027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233HR2013PTC049371

  • Registration Number

    049371

  • Incorporation Date

    29 May 2013

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 16.54%
  • Profit Growth **** 9.09%
  • Ebitda **** 10.68%
  • Net Worth 41.72%
  • Total Assets **** 9.36%
Company report

H.S. Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into H.S. Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at H.S. Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilbag Singh Director 29 May 2013 Current
Ram Paul Director 29 May 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of H.S. Pharma.

H.S. Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.54% increase. The company also saw a slight improvement in profitability, with a 9.09% increase in profit. The company's net worth Soared by an impressive increase of 41.72%.

H.S. Pharma revenue growth over time
H.S. Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.54%
*******
*******
*******
*******
Revenue from Operations
*******
 16.22%
*******
*******
*******
*******
Total Assets
*******
 9.36%
*******
*******
*******
*******
Profit or Loss
*******
 9.09%
*******
*******
*******
*******
Net Worth
*******
 41.72%
*******
*******
*******
*******
EBITDA
*******
 10.68%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of H.S. Pharma?

Unlock access to H.S. Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at H.S. Pharma?

Unlock and access historical data on people associated with H.S. Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of H.S. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H.S. Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on H.S. Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on H.S. Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on H.S. Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    The activity Dilbag Singh was appointed as a Director was appointed as a Director on 29 May 2013 & has been associated with this company since 12 years 8 months . was completed.

  • Director Appointment

    The activity Ram Paul was appointed as a Director was appointed as a Director on 29 May 2013 & has been associated with this company since 12 years 8 months . was completed.

  • Company Incorporation

    Progress on H.S. Pharma Private Limited was registered on 29 May 2013 with Roc Delhi & aged 12 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of H.S. Pharma Private Limited?

The CIN of H.S. Pharma Private Limited is U24233HR2013PTC049371.

Where is H.S. Pharma Private Limited headquartered?

H.S. Pharma Private Limited is headquartered at 189 A/16, Nehru Garden Near Jat School, Kaithal, Haryana, 136027.

When was H.S. Pharma Private Limited incorporated?

H.S. Pharma Private Limited was incorporated on 29 May 2013.

Who are the current directors of H.S. Pharma Private Limited?

The current directors of H.S. Pharma Private Limited are

What is the primary industry of H.S. Pharma Private Limited?

The primary industry of H.S. Pharma Private Limited is Trade.

Is H.S. Pharma Private Limited a listed company?

H.S. Pharma Private Limited is unlisted.

What is the capital structure of H.S. Pharma Private Limited?

The authorized capital of H.S. Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of H.S. Pharma Private Limited?

The compliance status of H.S. Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available